Cargando…
Use of anti-androgenic 5α-reductase inhibitors and risk of oesophageal and gastric cancer by histological type and anatomical sub-site
BACKGROUND: To investigate if anti-androgenic medications 5α-reductase inhibitors (5-ARIs) decrease the risk of developing oesophageal and gastric tumours, analysed by histological type and anatomical sub-site. METHODS: A Swedish population-based cohort study between 2005 and 2018 where men using 5-...
Autores principales: | Rabbani, Sirus, Santoni, Giola, Lagergren, Jesper, Xie, Shao-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427733/ https://www.ncbi.nlm.nih.gov/pubmed/35715630 http://dx.doi.org/10.1038/s41416-022-01872-w |
Ejemplares similares
-
Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study
por: Zheng, Jiaojiao, et al.
Publicado: (2019) -
Mortality in gastro-oesophageal reflux disease in a population-based nationwide cohort study of Swedish twins
por: Ness-Jensen, Eivind, et al.
Publicado: (2020) -
Dietary Proportions of Carbohydrates, Fat, and Protein and Risk of Oesophageal Cancer by Histological Type
por: Lagergren, Katarina, et al.
Publicado: (2013) -
Non-erosive gastro-oesophageal reflux disease and incidence of oesophageal adenocarcinoma in three Nordic countries: population based cohort study
por: Holmberg, Dag, et al.
Publicado: (2023) -
Haemoglobin A1c and serum glucose levels and risk of gastric cancer: a systematic review and meta-analysis
por: Zheng, Jiaojiao, et al.
Publicado: (2022)